$1.2-Million Loss for Cortex Pharmaceuticals

Irvine-based Cortex Pharmaceuticals Inc. posted a loss of $1.2 million, or 12 cents a share, for the fiscal first quarter ended Sept. 30, compared with a loss of $1.3 million, or 14 cents a share, for the same period a year ago. The company reported no revenue.